Human Factors and Usability under EU MDR/IVDR2025-08-29T10:25:54+05:30

our approach aimed at maximizing productivity & efficiency.

Human Factors and Usability under EU MDR/IVDR

The European Union Medical Device Regulation (EU MDR 2017/745) and the In Vitro Diagnostic Medical Device Regulation (EU IVDR 2017/746) place strong emphasis on human factors and usability engineering as integral parts of device safety and performance. Both regulations recognise that many adverse events and device related incidents are caused not by technical malfunctions but by use errors linked to poor design, unclear instructions, or failure to consider the abilities and limitations of the intended users.

To address this, MDR and IVDR require manufacturers to demonstrate that devices are designed and manufactured in a way that ensures safe, effective, and intuitive use across the full range of intended users whether healthcare professionals, patients, or lay-man and within the environments where the devices will be used, such as hospitals, laboratories, or home settings. These requirements are reflected in the General Safety and Performance Requirements (Annex I) of both regulations, which specifically call for usability considerations in areas like labeling, instructions for use, device interface, and risk control.

Compliance is closely tied to standards such as ISO 62366-1 (Usability Engineering for Medical Devices) and ISO 14971 (Risk Management), ensuring that usability is systematically evaluated throughout design, risk management, and clinical evaluation. For IVDs, usability plays a crucial role in preventing misinterpretation of test results, ensuring that lay users and professionals alike can operate devices correctly and consistently.

In short, under EU MDR and IVDR, human factors and usability are not optional, they are mandatory requirements that must be addressed in the technical documentation, risk management files, and clinical/performance evaluation reports to achieve CE certification.

MDR 2017/745 Requirements on Human Factors & Usability

  • General Safety and Performance Requirements (Annex I)

    • Annex I, Chapter I, Section 5: Devices must be designed and manufactured in such a way that, when used under the intended conditions, they are suitable for their intended purpose and safe, taking into account the knowledge, experience, education and training, and the environment of the intended users. This directly requires considering human factors.
    • Annex I, Chapter II, Section 14.2 (c, d, e): Usability of controls, displays, and user interfaces must minimize use error. Instructions for use, training needs, and design elements must support safe use.
    • Annex I, Section 23.4 (IFU requirements): Information must be understandable by the intended user (patient, lay user, healthcare professional).
  • Integration with Risk Management

    • Human factors are tied to risk management per ISO 14971.
    • MDR requires identification and reduction of use related risks (errors due to design, labelling, IFU, etc.).
    • Risk benefit analysis must account for misuse risks foreseeable with normal use.
  • Clinical Evaluation / Performance Evaluation connection

    • Clinical data must show that users can operate the device safely and effectively.
    • Any user related issues identified in clinical investigations, PMCF (Post-Market Clinical Follow-up), or vigilance must feed back into usability updates.
    • Any user related issues identified in Performance evaluation Post Market Performance Follow Up (PMPF), or vigilance must feed back into usability updates.
  • Documentation in the Technical File

    Manufacturers must include a Usability Engineering File (per ISO 62366-1) inside the Technical Documentation:

    • User profiles (who will use it – clinician, patient, lay caregiver).

    • Intended use environments (hospital, home, ambulance, etc.).

    • Critical tasks and associated use errors.

    • Formative and summative usability evaluations.

    • Residual use related risks and mitigations.

    • Traceability between risk analysis (ISO 14971), usability findings, and final design

predictive machines

Fusce dui est ultricies nec ultricies acd porttitor quis tellus ned.

certified factory

Fusce dui est ultricies nec ultricies acd porttitor quis tellus ned.

service related FAQ’s

Who needs to comply with EU MDR 2017/745?2025-08-03T08:55:10+05:30

All medical device manufacturers intending to sell devices in the EU, including Class I, IIa, IIb, and III must comply with the MDR.

Can usability studies replace clinical evaluation?2025-08-27T15:09:16+05:30

No. Human Factors studies complement but do not replace clinical evaluation. They specifically assess device-user interaction, whereas clinical evaluation assesses clinical performance, safety, and benefits.

Responsibilities of US Agent?2025-07-31T14:14:34+05:30

Foreign manufactures and exporters interested in selling medical devices in the USA can approach us. Our extensive knowledge of FDA regulations will aid in a smooth and efficient registration process. We the US Agents awake and answer any time when authorities ask for information. In addition to our US office, we have offices in Germany, India, Malaysia, UK and Vietnam.

We are not just like others, we have a big team of device experts, consultants and project managers who can handle any type of service to your organization.

The US Agent Service is vital for FDA medical device registration of foreign medical and in-vitro diagnostic devices manufacturers and initial exporters.

Check the responsibilities of the US agents.

Can RegHelps handle PMCF for devices already on the market?2026-03-30T10:48:43+05:30

Absolutely. We can take over Post Market Clinical Follow Up activities for devices already CE-marked and on the EU market, ensuring that your data collection, evaluation, and reporting fully meet MDR requirements — even if your existing documentation needs corrective action before the next Notified Body audit.

Is GMP compliance mandatory for medical device manufacturers?2025-08-06T04:26:10+05:30

Yes, GMP compliance is mandatory for medical device manufacturers who market products in the United States. The FDA enforces GMP through the Quality System Regulation (21 CFR Part 820), which outlines the minimum requirements for design, production, labeling, packaging, and storage of medical devices to ensure safety and effectiveness.

get a free quote
Go to Top